Literature DB >> 10091785

Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma.

Y Okusa1, T Ichikura, H Mochizuki.   

Abstract

BACKGROUND: Urokinase-type plasminogen activator (uPA) plays an important role in the destruction of the extracellular matrix and basement membrane around cancer cells. In the current study, the authors investigated uPA expression in cancer cells and stromal cells in patients with gastric carcinoma.
METHODS: uPA activity was determined by an enzymatic assay using synthetic substrate (S-2444) in tumor specimens obtained from 71 patients with gastric carcinoma and was compared with the results of immunohistochemical staining for uPA.
RESULTS: Higher uPA activity was significantly associated with tumors with peritoneal metastases and tumors with deeper invasion into the gastric wall. Undifferentiated tumors showed significantly higher uPA activities compared with differentiated tumors. The 25 patients with high uPA activity (> or = 60 U/mg protein) had a lower survival rate than the 46 patients with low uPA activity (< 60 U/mg protein) (P < 0.05). uPA activity showed prognostic significance in patients with International Union Against Cancer Stage II and Stage III tumors (P < 0.05, respectively). There was no significant relation between immunohistochemical expression of uPA in cancer cells and uPA enzymatic activity. However, uPA expression in stromal cells significantly correlated with uPA activity in tumor tissues. The uPA expression in stromal cells also correlated with tumor histology and peritoneal metastases.
CONCLUSIONS: These results suggest that uPA enzymatic activity is a prognostic factor in gastric carcinoma, and that uPA produced by stromal cells may regulate cancer cell invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091785

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.

Authors:  Alexander R Novotny; Christoph Schuhmacher; Raymonde Busch; Michael W Kattan; Murray F Brennan; Jörg Rüdiger Siewert
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  Tissue-type plasminogen activator activity in morphologically normal tissues adjacent to gastrointestinal carcinomas is associated with the degree of tumor progression.

Authors:  Gabriel Scicolone; Viviana Sanchez; Liliana Vauthay; Federico Fuentes; Alejandro Scicolone; Lorenzo Scicolone; Melina Rapacioli; Vladimir Flores
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-21       Impact factor: 4.553

Review 3.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

Review 4.  The next thing in prognostic molecular markers: microRNA signatures of cancer.

Authors:  William M Grady; Muneesh Tewari
Journal:  Gut       Date:  2010-06       Impact factor: 23.059

5.  Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.

Authors:  Oscar Vidal; Antonio Soriano-Izquierdo; Manuel Pera; José I Elizalde; Antonio Palacín; Antoni Castells; Josep M Piqué; Alain Volant; Jean P Metges
Journal:  J Gastrointest Surg       Date:  2007-10-31       Impact factor: 3.452

6.  Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment.

Authors:  Shigeki Suzuki; Genichiro Ishii; Rie Matsuwaki; Shinya Neri; Hiroko Hashimoto; Chisako Yamauchi; Keiju Aokage; Tomoyuki Hishida; Junji Yoshida; Mitsutomo Kohno; Kanji Nagai; Atsushi Ochiai
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-11       Impact factor: 4.553

Review 7.  The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.

Authors:  Daniel Brungs; Julia Chen; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  Oncotarget       Date:  2017-04-04

8.  Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.

Authors:  Yang-Kyu Choi; Byung-Il Yoon; Yoon-Hoh Kook; Young-Suk Won; Jin-Hyun Kim; Chul-Ho Lee; Byung-Hwa Hyun; Goo-Taeg Oh; John Sipley; Dae-Yong Kim
Journal:  Jpn J Cancer Res       Date:  2002-02

9.  Clinical significance of the uPA system in gastric cancer with peritoneal metastasis.

Authors:  Youcheng Ding; Hui Zhang; Mingan Zhong; Zhuqing Zhou; Zhixiang Zhuang; Hua Yin; Xujing Wang; Zhenggang Zhu
Journal:  Eur J Med Res       Date:  2013-08-28       Impact factor: 2.175

10.  Effects of 3-Tetrazolyl Methyl-3-Hydroxy-Oxindole Hybrid (THOH) on Cell Proliferation, Apoptosis, and G2/M Cell Cycle Arrest Occurs by Targeting Platelet-Derived Growth Factor D (PDGF-D) and the MEK/ERK Signaling Pathway in Human Lung Cell Lines SK-LU-1, A549, and A-427.

Authors:  Peng Li; Zhiqiang Zhang; Feng Zhang; Hongling Zhou; Bei Sun
Journal:  Med Sci Monit       Date:  2018-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.